Ralliant Corporation (NYSE:RAL) Short Interest Update

Ralliant Corporation (NYSE:RAL) was the target of a significant growth in short interest in the month of February. As of February 13th, there was short interest totaling 4,566,002 shares, a growth of 21.8% from the January 29th total of 3,747,948 shares. Currently, 4.0% of the shares of the stock are short sold. Based on an average daily volume of 3,777,582 shares, the days-to-cover ratio is presently 1.2 days. Based on an average daily volume of 3,777,582 shares, the days-to-cover ratio is presently 1.2 days. Currently, 4.0% of the shares of the stock are short sold.

Analyst Ratings Changes

A number of analysts have recently commented on RAL shares. Citigroup dropped their price objective on Ralliant from $61.00 to $51.00 and set a “buy” rating on the stock in a research note on Friday, February 6th. Barclays dropped their price target on shares of Ralliant from $60.00 to $52.00 and set an “overweight” rating on the stock in a research report on Monday, February 9th. Vertical Research upgraded shares of Ralliant from a “hold” rating to a “buy” rating and set a $45.00 price objective for the company in a research report on Friday, February 6th. Zacks Research downgraded shares of Ralliant from a “hold” rating to a “strong sell” rating in a report on Monday, February 9th. Finally, Weiss Ratings lowered shares of Ralliant from a “hold (c)” rating to a “sell (d)” rating in a research note on Thursday, February 5th. Seven research analysts have rated the stock with a Buy rating, three have issued a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $50.50.

Ralliant Stock Performance

Shares of RAL opened at $45.81 on Wednesday. The company has a 50-day moving average of $49.28 and a two-hundred day moving average of $46.63. The stock has a market cap of $5.12 billion and a price-to-earnings ratio of 23.37. The company has a debt-to-equity ratio of 0.38, a current ratio of 0.84 and a quick ratio of 0.58. Ralliant has a one year low of $37.27 and a one year high of $57.02.

Ralliant (NYSE:RAL) last issued its quarterly earnings results on Wednesday, February 4th. The company reported $0.69 EPS for the quarter, beating the consensus estimate of $0.67 by $0.02. The firm had revenue of $554.60 million during the quarter, compared to analysts’ expectations of $543.04 million. The business’s revenue was up 1.2% on a year-over-year basis. Ralliant has set its Q1 2026 guidance at 0.460-0.520 EPS and its FY 2026 guidance at 2.220-2.420 EPS.

Ralliant Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, March 23rd. Investors of record on Monday, March 9th will be given a dividend of $0.05 per share. This represents a $0.20 annualized dividend and a yield of 0.4%. The ex-dividend date of this dividend is Monday, March 9th. Ralliant’s payout ratio is presently 10.20%.

Insider Activity at Ralliant

In related news, Director Anelise Angelino Sacks bought 2,000 shares of the stock in a transaction on Monday, February 9th. The shares were purchased at an average price of $41.25 per share, with a total value of $82,500.00. Following the purchase, the director owned 5,403 shares in the company, valued at approximately $222,873.75. This represents a 58.77% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Kate Mitchell purchased 2,350 shares of the company’s stock in a transaction on Tuesday, February 10th. The shares were bought at an average price of $42.48 per share, for a total transaction of $99,828.00. Following the completion of the transaction, the director directly owned 8,411 shares in the company, valued at $357,299.28. This represents a 38.77% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Over the last quarter, insiders have bought 8,145 shares of company stock worth $332,233.

Hedge Funds Weigh In On Ralliant

Several institutional investors and hedge funds have recently bought and sold shares of the business. Envestnet Asset Management Inc. acquired a new position in shares of Ralliant in the 2nd quarter valued at about $4,922,000. Bessemer Group Inc. purchased a new stake in Ralliant in the 2nd quarter worth approximately $108,000. Y Intercept Hong Kong Ltd purchased a new stake in Ralliant in the 2nd quarter worth approximately $623,000. Teacher Retirement System of Texas acquired a new stake in shares of Ralliant during the 2nd quarter valued at $835,000. Finally, Keybank National Association OH purchased a new position in shares of Ralliant during the 2nd quarter valued at $798,000.

Ralliant Company Profile

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.